when managing dogs with DMVD in practice. 4, 5 Furthermore, owners of dogs with cardiac disease can experience high levels of concern and anxiety regarding uncertainty in their pets' likely longevity. 6 Identifying prognostic factors thus could aid veterinary practitioners when managing dogs with DMVD and help inform dog owners of their pets' likely outcome. In addition, risk stratification based on prognostic information could help identify dogs for inclusion into large-scale clinical trials. 7 Echocardiographic and radiographic indices of cardiac enlargement and mitral regurgitation severity have prognostic value in dogs with DMVD. [3] [4] [5] [8] [9] [10] [11] [12] [13] [14] [15] However, the equipment and expertise required to perform these procedures and interpret the findings might not be readily available in primary care practice. 9, 16 Moreover, inter-observer variation might influence the results of radiography and echocardiography, 17, 18 distressed animals might not tolerate being restrained for diagnostic imaging 19 and the procedures might pose some risk to the patient, should sedation or anesthesia be required. 20 It would, therefore, be desirable to identify prognostic risk factors that can be readily measured in the primary care setting, particularly if diagnostic imaging is not available. Cardiac biomarker blood tests and data derived from history taking and physical examination findings have shown promise as predictors of outcome. 5, 9, 13, 21 However, previous studies analyzed clinical data recorded by veterinary cardiologists, and it is unclear whether the results are applicable to first opinion practice.
Our aim was to prospectively follow dogs with presumptive DMVD attending primary care practices in the United Kingdom to evaluate the prognostic value of key clinical and biochemical measurements in this setting.
The objectives of this study were to:
1. Determine whether plasma cardiac biomarker concentrations are associated with all-cause mortality and/or cardiac-related death in dogs diagnosed with DMVD attending primary care practices; and,
Evaluate whether biomarker data can be used in combination with
clinical signs and physical examination findings to risk stratify affected animals.
It was hypothesized that circulating plasma concentrations of Nterminal pro B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) would be associated with an increased hazard of allcause and cardiac-related death in dogs with DMVD attending primary care practices. Furthermore, it was hypothesized that historical and physical examination factors also would be associated with the hazard of death and would thus provide complementary prognostic information.
| MATERIALS AND METHODS
A prospective cohort design was used to evaluate associations between explanatory (risk factor) variables and mortality in dogs with a presumptive diagnosis of DMVD. A convenience sample of UK primary care veterinary practices was recruited by publication of letters and articles in the veterinary press and social media. Furthermore, veterinary societies, canine welfare organizations, the UK Kennel Club, 22 and veterinary cardiologists promoted the study. Letters inviting participation were sent to 294 practices. Recruitment efforts also were directed toward practices that took part in the Veterinary Companion Animal Surveillance System (VetCompass) program 23 and practices that were part of large veterinary groups by emails, newsletters, a continuing professional development event and an internal conference. Ethics approval for the study was obtained from the Royal Veterinary College's Ethics and Welfare Committee (URN 2012 1144).
Dogs diagnosed with DMVD were recruited to the study by veterinarians during episodes of care or by letters inviting participation.
Cases were defined as dogs with a veterinary diagnosis of DMVD attending collaborating primary care practices in the United Kingdom.
Diagnosis could be presumptive and based on clinical findings alone (left apical systolic heart murmur in a dog of typical signalment). Confirmation by echocardiography was not an inclusion criterion. Dogs with any stage of the disease were eligible for inclusion. Age and breed restrictions were not imposed so as to maximize the external validity of the results. At recruitment, veterinarians obtained written owner consent, recorded clinical data on a specially designed form and collected a 2 mL venous blood sample for cardiac biomarker measurement from the dog. Clinical data collected included heart rate, heart rhythm, and heart murmur intensity and the presence or absence of coughing, dyspnea, and exercise intolerance. Veterinarians were instructed to ask dog owners to record the pet's sleeping respiratory rate (SRR) as the respiratory rate when the dog appeared to be sleeping deeply in the home environment, when it was neither too hot nor too cold. 24 Plasma NT-proBNP was measured using a second generation ELISA test (Cardiopet ® proBNP) and cTnI was measured using a 2-site immunoenzymatic sandwich assay (Beckman Access 2 Troponin assay) at a commercial laboratory (IDEXX laboratories, Wetherby,
The United Kingdom). Electronic patient records (EPRs) for recruited cases were either uploaded to the VetCompass database, if participating in the program, 23 or otherwise shared by email, post, or facsimile.
Date of birth, breed, sex, neuter status, and body weight were extracted from the EPRs and entered into a relational database (Access 2010, Microsoft Corporation, Redmond, Washington). The diagnostic tests and therapeutic interventions used to investigate and treat the dogs' heart disease also were extracted. Any documented comorbidities, respiratory rates (RRs) and whether the dog was insured also were recorded in the database whenever reported in the EPRs.
In DMVD cases that died during the study, the date, modality (euthanasia versus natural) and cause of death were extracted where available. If a dog was not reported to have died, it was censored on the date that it was last known to be alive. Cardiac-related death was defined as spontaneous death or euthanasia primarily because of clinical signs consistent with heart disease or sudden death. 
| Descriptive statistics
Continuous data were assessed graphically for normality and presented as mean and standard deviation (SD) or median and interquartile range (IQR) as appropriate. For categorical variables, the number and percentage within each category were presented. For time-toevent analyses, the median time at risk was defined as the median time from recruitment until experiencing an event or censoring.
| Cox proportional hazard and flexible parametric models
The following explanatory variables were evaluated in the time-to-event 31, 32 The predictive ability of the models was evaluated using Harrell's C concordance statistic. 31 Martingale residuals were used to assess the functional form of the relationship between continuous variables and the outcome. 32 To identify outliers and individuals with a disproportionate influence, deviance residuals and likelihood displacements measures were plotted, respectively. 31, 32 Changes in model coefficients were assessed when individuals with the greatest deviance residuals and influence were excluded from the models. Dogs with missing data for any of the final model variables were excluded from the multivariable models.
Royston-Parmar flexible parametric models were used to predict survival probabilities (for cardiac-related death) and explore alterna- 
| Evaluating respiratory rate as an explanatory variable
Due to missing data, RR was not evaluated as an explanatory variable in the multivariable models. However, univariable Cox regression models were constructed to explore the associations between both SRR measured in the home environment and RR measured at the veterinary practice and mortality.
| Sample size calculations
A priori sample size calculations estimated that approximately 100 deaths would be required to detect a HR of 2 for a variable to which 20% of individuals were exposed, at a confidence level of 95%
and power of 80%. It was estimated that 650-700 dogs would need to be recruited to the study over an 18-month accrual period and a minimum 6 months follow-up, assuming a 10% loss to follow-up. 36 3 | RESULTS
| Study population
Eight-hundred and ninety-three dogs were recruited between 19th as not having DMVD after recruitment (10 dogs were diagnosed with an alternate disorder and 5 did not have a documented heart murmur).
These animals were included in analyses because the sample recruited to the study consisted of dogs that primary care veterinarians presumptively diagnosed with DMVD, which was the intended population to which the study results apply. Excluding these cases from the multivariable analyses had minimal impact on the model coefficients.
Fourteen dogs had no follow-up data or had an unknown date of death and were excluded from the survival analysis.
For dogs included in the survival analysis, the total analysis time 
| Prognostic risk factors associated with allcause mortality
The following explanatory variables were evaluated in multivariable Cox models because there was some evidence for associations (P < . 2) between these variables and hazard of death (all-cause mortality) in univariable analysis: age, sex, breed, insurance status, plasma NTproBNP, plasma cTnI, cough, dyspnea, exercise intolerance, heart rhythm, heart rate, heart murmur intensity, cardiac treatments prescribed, and comorbidities. The final multivariable model included the following explanatory variables: age, sex, plasma NT-proBNP, plasma cTnI, presence of dyspnea and exercise intolerance, heart rate, and documented diagnosis of selected musculoskeletal disorders, neoplasia, or renal disease (Table 3 ). There was an interaction between NTproBNP and age, such that the association between NT-proBNP and mortality was stronger in dogs ≤9.5 years old compared with older dogs (P = .003). Veterinary clinic was significant when included as a shared frailty term, indicating clustering of data at the practice level.
No major violations of the PH assumption were identified and CoxSnell residuals indicated that the model fit the data reasonably well.
Harrell's C concordance statistic was 0.79, suggesting the discriminatory ability of the model was good. Martingale residuals supported that heart rate could be included as an untransformed linear variable.
Changes in coefficients were minimal when individuals with the greatest deviance residuals and influence were excluded from the model. The following explanatory variables had some evidence (P < .2) of an association with cardiac-related death in univariable analysis and were taken forward for consideration in the multivariable model: age, body weight, breed, plasma NT-proBNP, plasma cTnI, cough, dyspnea, exercise intolerance, heart rhythm, heart rate, heart murmur intensity, cardiac treatments prescribed, and diagnosis of an endocrinopathy. In the multivariable model, higher plasma NT-proBNP and cTnI concentrations, higher murmur intensities and heart rates, exercise intolerance, and receiving potent diuretics at recruitment were independently associated with increased hazards of cardiac-related death (Table 4) . Veterinary clinic was included as a shared frailty term, indicating clustering of data within practices. The Schoenfeld residuals test was statistically significant, providing evidence that the PH assumption was violated and cTnI was found to have a statistically significant time-dependent effect (the magnitude of the HR between the highest and lowest terciles of the biomarker decreased over time, violating the PH assumption). Some evidence for an interaction was found between heart murmur intensity and diuretic administration (P = .032). It is possible that the interaction was related to data sparsity within certain categories and this finding was (Table 5 ). On the PO scale, the HR for the association between categories converges toward 1 over Table 6 ). Hazard of cardiac-related death increased 1.06 times (95% CI, 1.04-1.09) for each unit increase in SRR (Table 7) . Veterinarians recorded respiratory rate during episodes of care for 226 cases. Eleven dogs had no follow- Table 6 ). The hazard of cardiac-related death increased 1.04 times (95% CI, 1.03-1.05) for each unit increase in RR (Table 7) .
| Prognostic value of respiratory rates

| DISCUSSION
We identified a number of clinical findings that were associated with survival in a heterogeneous cohort of dogs with presumed DMVD evaluated at primary care veterinary practices in the United Kingdom.
The prognostic utility of a combination of measurements was greater than that of any measurement in isolation. Taking a history, performing a physical examination, and measuring plasma cardiac biomarkers when evaluating dogs with presumed DMVD thus could aid prognostication and direct further management of cases, particularly if echocardiography or thoracic radiography are unavailable.
| Cardiac biomarkers
Plasma concentration of NT-proBNP was among the strongest predictors of all-cause and cardiac-related mortality. These findings concur with previous studies indicating that NT-proBNP is associated with survival in dogs with DMVD. 5, 9, 37, 38 Circulating NT-proBNP is a marker of myocardial wall stress as a result of volume or pressure overload. 39 High concentrations of the marker therefore might reflect more advanced DMVD and a higher risk of death in dogs. An interaction was found between age and NT-proBNP in the model for allcause mortality, with the association between the biomarker and hazard of death being attenuated in dogs > 9.5 years old. Cox regression models specifying non-cardiac death as the outcome event of interest identified strong associations between age and death, but failed to find an association between NT-proBNP and hazard of non-cardiac mortality (data not shown). It therefore can be speculated that the ability of NT-proBNP to predict all-cause mortality in a cohort of dogs with DMVD is chiefly attributable to the strong association between the biomarker and cardiac-related death. When evaluating all-cause mortality in older dogs, the association between NT-proBNP and mortality might therefore be diluted by the increased hazard of death due to non-cardiac disease in geriatric animals. This interaction also might have occurred as a result of a positive correlation between age and NT-propBNP, independent of disease severity, as has been reported in humans. 40 However, to our knowledge, this association has not been reported in dogs, and an interaction between age and NTproBNP was not observed in the model evaluating factors associated with cardiac-related mortality.
In contrast, cardiac troponins are released into the circulation after myocardiocyte injury, which can be due to primary heart disease or secondary to non-cardiac disorders. 29 Circulating cTnI is a sensitive and specific marker of cardiac injury (regardless of the underlying cause) and increased concentrations have been reported in dogs with many cardiac and non-cardiac diseases. 29 These findings are consistent with those of the current study, which identified strong evidence for associations between plasma cTnI and both all-cause mortality and cardiac-related death. Furthermore, time-to-event models specifying non-cardiac death as an outcome confirmed an association between cTnI and non-cardiac mortality (data not shown), highlighting that the prognostic utility of the marker is less specific to cardiac-related mortality than NT-proBNP. The two studied biomarkers, therefore, give different prognostic information; NT-proBNP was a more specific marker of cardiac-disease severity, whereas cTnI had a strong association with mortality, regardless of cause.
The time-dependent effect identified suggests that the ability of cTnI to predict cardiac-related death is greatest in the short-to medium-term after sampling. Moreover, flexible parametric survival models on the PO scale had a superior fit to models on the PH scale, providing further evidence that the magnitude of effect (HR) of the biomarkers is greatest in the months immediately after sampling.
Several physiological and pathological factors can influence the reported concentrations of both NT-proBNP and cTnI, potentially confounding the associations between the biomarkers and survival. 26, 27, 29, 38, [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] Breed, sex, body weight, age, treatments, and comorbidities were evaluated both as explanatory variables and confounders in our study. Coefficients were only marginally different when variables excluded from the multivariable models were individually added to the final models, indicating minimal confounding. However, misclassification of potential confounders was possible and only the most common breeds, treatments, and disorders were evaluated.
Furthermore, fluctuations in circulating biomarker concentrations might have introduced measurement error because inherent biological variability in both NT-proBNP and cTnI has been reported in dogs with DMVD. 57, 58 Finally, sample handling and storage conditions might influence cardiac biomarker assay results. 59, 60 However, to be clinically useful, a diagnostic test should be evaluated in the conditions under which it will be used in practice 61 and the prognostic value of NT-proBNP and cTnI was confirmed, despite potential variation in sample handling and storage.
| Presenting signs, clinical findings, and signalment
Higher heart rates were associated with increased hazards of an adverse outcome in agreement with a number of studies. [3] [4] [5] 8, 12, 62 Decreased cardiac output and arterial hypotension as a result of DMVD elicit a decrease in vagal tone and increase the activity of the sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS). 63 A major effect of these systems is catecholamine release resulting in an increase in heart rate. 64, 65 These compensatory mechanisms serve a beneficial function in the short term by maintaining cardiac output and blood pressure. However, a chronic increase in SNS and RAAS activity increases myocardial oxygen consumption and induces myocardial hypertrophy and fibrosis, thereby contributing to the progression of the disease. 63, 66 Therefore, increased heart rate might be both a risk factor for and a consequence of disease progression in dogs with DMVD, and is thus associated with a worse prognosis.
Heart murmur intensity also was associated with cardiac-related death, in agreement with a previous report. 21 Heart murmur intensity reflects regurgitant volume and correlates with DMVD severity in small breed dogs, 67, 68 consistent with the observed associations between this measurement and hazard of cardiac-related death.
Exercise intolerance and dyspnea were associated with all-cause mortality and cardiac-related death, in agreement with other studies. 3, 12, 21 The association between dyspnea and cardiac death did not persist in multivariable analysis, which might be due to the limited number of dogs with dyspnea or the lower number of events in the cardiac-related death model compared with the all-cause mortality model. Exercise intolerance and dyspnea are associated with more advanced DMVD 12, 18, 21, 69, 70 and can have an adverse impact on quality of life, 6, 71, 72 which is an important factor when dog owners are considering euthanasia. 6, 73 Because the majority of dogs with DMVD that died were euthanized, factors perceived to affect quality of life, therefore, are likely to be associated with hazard of death. The presence of a cough was significantly associated with both all-cause and cardiac-related mortality in univariable analysis. This association did not persist in multivariable analysis in contrast to the findings of another study of UK dogs with DMVD. 21 This discrepancy might be due to inclusion of different variables in the multivariable models (the latter study did not evaluate cardiac biomarkers and included some clinical measurements not included in our study).
Respiratory rate showed promise as a predictor of mortality in univariable analysis. The magnitude of effect was stronger for SRR than RR measured at the practice, which might reflect that the latter measurement is more likely to be influenced by non-cardiac factors, such as stress or excitement related to visiting the veterinary practice.
To our knowledge, the prognostic value of RR in dogs with DMVD has not previously been described, although there is evidence supporting that this measurement is an indicator of heart disease severity. 18, 74, 75 Advancing age was associated with an increased hazard of death due to all-cause mortality in dogs with DMVD, consistent with previous reports. 3, 5, 8, 9 In contrast to previous studies, 3, 5, 8, 9 sex was an independent risk factor for all-cause mortality, with males having a lower hazard of death than females. This association might reflect sex differences in the risk of death due to non-cardiac disorders or type I error.
| Comorbidity and treatment
Diagnoses of neoplasia, renal disease, and musculoskeletal disease were significant risk factors in the multivariable model for all-cause mortality. These disorders have been reported to be major causes of mortality in the wider population of dogs attending primary care practice. 76 Hematology and biochemistry were not routinely performed and adjunct diagnostic tests were performed at the discretion of the attending veterinarian. Under-reporting and misclassification of evaluated comorbidities therefore was possible, which might have attenuated confounding effects or biased associations with hazard of death toward the null.
Receiving a potent diuretic was associated with an increased hazard of experiencing cardiac-related death. It is likely that these treatments are a proxy for dogs with a history of CHF, which have more advanced disease and thus an increased hazard of death. However, the rationale behind prescribing potent diuretics was not explored and some dogs without CHF might have inappropriately received diuretics.
An alternative approach would have been to classify dogs based on their heart disease stage or whether they had a documented diagnosis of CHF. However, DMVD severity grading schemes require diagnostic imaging to stage the disease 77 and these procedures were not routinely performed. Administration of potent diuretics was evaluated rather than a documented diagnosis of CHF, because it was considered that prescribed treatments essential for dogs with CHF 77 would be more reliably recorded in electronic patient records than diagnoses of CHF.
| General strengths and limitations
Our study benefitted from a prospective cohort design, which provides the highest strength of evidence of single observational studies. 31 Furthermore, 893 dogs were recruited by 79 practices, which, to our knowledge, is the largest prospective study of DMVD in dogs under the care of first opinion practitioners. Nonetheless, several limitations should be acknowledged. The practitioners' diagnoses of DMVD were accepted to be correct and strict eligibility criteria were not imposed. Although this pragmatic approach maximizes the external validity of the results, 78 it is possible that dogs erroneously diagnosed with DMVD were recruited to the study. However, almost all (260/268, 97.0%) of dogs that underwent echocardiography in our study had findings consistent with DMVD. In addition, participating clinicians were provided with information on typical presentation and risk factors for DMVD to improve the accuracy of presumptive diag- 81 However, despite data being collected under different conditions by a large number of practitioners, several clinical findings remained predictors of mortality. Moreover, these variables were measured before the outcome occurring, so the impact of misclassification is likely to be non-differential and bias associations toward the null.
Echocardiography and radiography were not routinely performed, so it was not possible to compare the prognostic value of the explanatory variables evaluated in our study with parameters obtained from diagnostic imaging. Another limitation of our study is that selection bias might have arisen because of censoring and missing data. An assumption of time-to-event models is that censoring is independent of the outcome of interest. 31 It is possible that right-censored dogs had different survival experiences as compared with those with more complete follow-up. Complete case analysis was used in the multivariable models, so bias might have been introduced if data were not missing randomly. 31 Also, the outcome of cardiac-related death is subjective and was largely based on what was recorded in EPRs. Cause of death can be complex and might variably involve heart disease. Study participants were not blinded to plasma cardiac biomarker concentrations and it is possible that lack of blinding influenced the assessment of whether clinical signs leading to death were cardiac-related, thus introducing observer bias. 82 Furthermore, management of DMVD cases was not 
